Rock Springs Capital Management LP - PHASEBIO PHARMACEUTICALS INC ownership

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 56 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$479,000
-71.2%
2,719,074
-2.0%
0.01%
-75.0%
Q2 2022$1,665,000
-51.7%
2,774,869
+6.2%
0.05%
-44.8%
Q1 2022$3,450,000
-48.8%
2,613,825
+1.3%
0.09%
-44.2%
Q4 2021$6,737,000
+17.5%
2,581,299
+40.0%
0.16%
+28.9%
Q3 2021$5,734,000
-16.4%
1,843,7640.0%0.12%
-11.0%
Q2 2021$6,859,000
+27.6%
1,843,764
+18.6%
0.14%
+16.2%
Q1 2021$5,377,000
+21.8%
1,553,974
+18.2%
0.12%
+24.5%
Q4 2020$4,416,000
-4.2%
1,314,374
+0.1%
0.09%
-19.7%
Q3 2020$4,609,000
-12.4%
1,313,174
+14.8%
0.12%
-18.8%
Q2 2020$5,262,000
+41.3%
1,143,925
+1.7%
0.14%
-6.5%
Q1 2020$3,724,000
-45.8%
1,125,0000.0%0.15%
-29.0%
Q4 2019$6,874,000
+16.4%
1,125,000
-20.6%
0.22%
-7.7%
Q3 2019$5,908,000
-68.4%
1,416,900
-0.4%
0.24%
-65.2%
Q2 2019$18,673,000
+72.2%
1,423,256
+24.8%
0.68%
+61.7%
Q1 2019$10,841,000
+320.2%
1,140,000
+36.5%
0.42%
+242.6%
Q4 2018$2,580,000835,0000.12%
Other shareholders
PHASEBIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Johnson & Johnson Innovation - JJDC, Inc. 1,607,044$5,400,0000.70%
NEA Management Company, LLC 6,643,704$22,323,0000.59%
DAFNA Capital Management LLC 320,542$1,077,0000.32%
Platform Technology Partners 141,025$474,0000.23%
Parkman Healthcare Partners LLC 110,547$371,0000.10%
Rock Springs Capital Management LP 1,314,374$4,416,0000.09%
GSA CAPITAL PARTNERS LLP 140,341$472,0000.08%
SABBY MANAGEMENT, LLC 65,000$218,0000.04%
Virtu Financial LLC 28,821$97,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 127,600$429,0000.01%
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders